Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course
Study Title
- A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course
Teva Identifier
- MS-LAQ-301E | 2009-012989-30
ClinicalTrials.gov Identifier
- NCT00988052
Study Status
- Terminated
Trial Condition(s)
- Relapsing Multiple Sclerosis
Interventions
- Drug: Laquinimod
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 55 Years
Trial Duration
- November 10, 2009 - July 1, 2017
Phase
- Phase 3
Study Type
Interventional
